In vivo recombinant adenovirus-mediated p53 gene therapy in a syngeneic rat model for colorectal cancer

Journal of Korean Medical Science

Volumn 19, Issue 6, 2004, Pages 834-841

  Baek, Jeong Heum ^a   Agarwal, Munna L ^b   Tubbs, Raymond R ^b   Vladisavljevic, Alex ^c   Tomita, Hiroshi ^b   Bukowski, Ronald M ^b   Milsom, Jeffrey W ^c   Kim, Jin Man ^d   Kwak, Jin Young ^e  

^a Gachon University   (South Korea)

^b LERNER RESEARCH INSTITUTE   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

^d Chungnam National University   (South Korea)

^e Hanyang University   (South Korea)

Author keywords

Colorectal Neoplasms; Gene Therapy; Protein p53; Recombinant Adenovirus; Transgenes

Indexed keywords

ANTINEOPLASTIC AGENT; PHOSPHATE BUFFERED SALINE; PROTEIN P53; RECOMBINANT PROTEIN;

ADENOVIRUS; ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; COLORECTAL CARCINOMA; CONTROLLED STUDY; EXPERIMENTAL NEOPLASM; EXPERIMENTAL RAT; GENE THERAPY; GENOMIC INSTABILITY; NICK END LABELING; NONHUMAN; RAT; STATISTICAL SIGNIFICANCE; TRANSGENE; TREATMENT OUTCOME; VIRUS RECOMBINANT;

EID: 12144275246     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2004.19.6.834     Document Type: Article

References (31)

1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ. Cancer Statistics, 2004. CA Cancer J Clin 2004; 54: 8-29.
2. Finlay IG, McArdle CS. Occult hepatic metastases in colorectal carcinoma. Br J Surg 1986; 73: 732-5.
3. Bozzetti F, Cozzaglio L, Boracchi P, Marubini E, Doci R, Bignami P, Gennari L. Comparing surgical resection of limited hepatic metastases from colorectal cancer to non-operative treatment. Eur J Surg Oncol 1993; 19: 162-7.
4. Kock H, Harris MP, Anderson SC, Machemer T, Hancock W, Sutjipto S, Wills KN, Gregory RJ, Shepard HM, Westphal M, Maneval DC. Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo. Int J Cancer 1996; 67: 808-15.
5. Lane DP, Crawford LV. Tantigen is bound to a host protein in SV40-transformed cells. Nature 1979; 278: 261-3.
6. Lane DP, Benchimol S. p53: oncogene or anti-oncogene? Gene Dev 1990; 4: 1-8.
7. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253: 49-53.
8. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 1991; 351: 453-6.
9. Bookstein R, Demers W, Gregory R, Maneval D, Park J, Wills K. p53 gene therapy in vivo of hepatocellular and liver metastatic colorectal cancer. Semin Oncol 1996; 23: 66-77.
10. Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990; 249: 912-5.
11. Agarwal ML, Taylor WR, Chernov MV, Chernova OB, Stark GR. The p53 network. J Biol Chem 1998; 273: 1-4.
12. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993; 74: 957-67.
13. Spitz FR, Nguyen D, Skibber JM, Cusack J, Roth JA, Cristiano RJ. In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer. Anticancer Res 1996; 16: 3415-22.
14. Agarwal ML, Agarwal A, Taylor WR, Stark GR. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA 1995; 92: 8493-7.
15. Agarwal ML, Agarwal A, Taylor WR, Wang ZQ, Wagner EF, Stark GR. Defective induction but normal activation and function of p53 in mouse cells lacking poly-ADP-ribose polymerase. Oncogene 1997; 15: 1035-41.
16. Ravikumar TS, D'Emilia J, Cocchiaro C, Wolf B, King V, Steele G Jr. Experimental liver metastasis. Implications of clonal proclivity and organ specificity. Arch Surg 1989; 124: 49-54.
17. Fidler JJ, Kripke ML. Metastasis results from preexisting variant cells within a malignant tumor. Science 1977; 197: 893-5.
18. Fidler IJ. Selection of successive tumour lines for metastasis. Nat New Biol 1973; 242: 148-9.
19. Liu TJ, Zhang WW, Taylor DL, Roth JA, Goepfert H, Clayman GL. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res 1994; 54: 3662-7.
20. Boviatsis EJ, Chase M, Wei MX, Tamiya T, Hurford RK Jr, Kowall NW, Tepper RI, Breakefield XO, Chiocca EA. Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors. Hum Gene Ther 1994; 5: 183-91.
21. Landegren U. Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens. J Immunol Methods 1984; 67: 379-88.
22. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
23. Bouvet M, Ellis LM, Nishizaki M, Fujiwara T, Liu W, Bucana CD, Fang B, Lee JJ, Roth JA. Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. Cancer Res 1998; 58: 2288-92.
24. Drazan KE, Csete ME, Da Shen X, Bullington D, Cottle G, Busuttil RW, Shaked A. Hepatic function is preserved following liver-directed, adenovirus-mediated gene transfer. J Surg Res 1995; 59: 299-304.
25. Drazan KE, Shen XD, Csete ME, Zhang WW, Roth JA, Busuttil RW, Shaked A. In vivo adenoviral-mediated human p53 tumor suppressor gene transfer and expression in rat liver after resection. Surgery 1994; 116: 197-203; discussion 203-4.
26. Zhang WW, Fang X, Mazur W, French BA, Georges RN, Roth JA. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther 1994; 1: 5-13.
27. Clayman GL, el-Naggar AK, Roth JA, Zhang WW, Goepfert H, Taylor DL, Liu TJ. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res 1995; 55: 1-6.
28. Kim J, Hwang ES, Kim JS, You EH, Lee SH, Lee JH. Intrapentoneal gene therapy with adenoviral-mediated p53 tumor suppressor gene for ovarian cancer model in nude mouse. Cancer Gene Ther 1999; 6: 172-8.
29. Harris MP, Sutjipto S, Wills KN, Hancock W, Cornell D, Johnson DE, Gregory RJ, Shepard HM, Maneval DC. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein. Cancer Gene Ther 1996; 3: 121-30.
30. Liu TJ, el-Naggar AK, McDonnell TJ, Steck KD, Wang M, Taylor DL, Clayman GL. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Cancer Res 1995; 55: 3117-22.
31. Colecchia M, Frigo B, Del Boca C, Guardamagna A, Zucchi A, Colloi D, Leopardi O. Detection of apoptosis by the TUNEL technique in clinically localized prostatic cancer before and after combined endocrine therapy. J Clin Pathol 1997; 50: 384-8.